David Redfern

Experience

• 

  Scotiabank

  Jan 2007 - Jan 2012

  Marketed and underwrote import finance facilities, receivable purchase facilities and letters of credit for some of the largest commodity importers and exporters in North and South America Supported commercial banking clients operating in a variety of industries including transportation, manufacturing, agriculture, consumer products and business services

  • Commodity Trade Finance

    Jan 2008 - Jan 2012

  • Commercial Banking

    Jan 2007 - Jan 2008
• 

  BMO Capital Markets

  Jan 2014 - Jan 2016

  Equity Research, U.S. Pharmaceuticals and Animal Health

  Coverage of AbbVie (ABBV), Bristol-Myers Squibb (BMY), Eli Lilly (LLY), Kindred Biosciences (KIN), Merck (MRK), Pfizer (PFE), Valeant Pharmaceuticals (VRX), Zoetis (ZTS)

• 

  Credit Suisse

  Jan 2016 - Jan 2018

  Investment Banking and Capital Markets, Diversified Industries

  M&A mandates, debt and equity fundraisings for public and private clients in telecom, transportation, healthcare, manufacturing, business services, infrastructure and financial services

• 

  Canerector

  Jan 2019 - now

  Canerector is a group of over 50 companies that design and manufacture industrial products across a wide range of industries.

  • Director, Strategy & Corporate Development

    Jan 2025 - now

  • Director, Corporate Development

    Jan 2019 - Jan 2025